Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Novel Anti-Myeloma Agents and Bone Metabolism: Implications in the Management of Myeloma Bone Disease — Evangelos Terpos (2009) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Novel Anti-Myeloma Agents and Bone Metabolism: Implications in the Management of Myeloma Bone Disease
Shared by
Meletios A Dimopoulos
Novel Anti-Myeloma Agents and Bone Metabolism: Implications in the Management of Myeloma Bone Disease
Article
2009
en
Authors
+3 more
ET
Evangelos Terpos
DC
Dimitrios Christoulas
EK
Efstathios Kastritis
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2007
The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma
Evangelos Terpos
,
Meletios A Dimopoulos
,
Orhan Sezer
Article
2008
Novel anti-myeloma agents and angiogenesis
Konstantinos Anargyrou
,
Meletios A Dimopoulos
,
Orhan Sezer
,
Evangelos Terpos
Article
2005
Myeloma bone disease: pathophysiology and management
Evangelos Terpos
,
Meletios A Dimopoulos
Article
2009
Pathogenesis and management of myeloma bone disease
Dimitrios Christoulas
,
Evangelos Terpos
,
Meletios A Dimopoulos
Article
2011
Advances in Imaging and the Management of Myeloma Bone Disease
Evangelos Terpos
,
Lia A. Moulopoulos
,
Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.